CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 48 target
Drug / intervention
Oseltamivir +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00304434
NCT00304434Phase 4Completed
CompareCT.gov

Oseltamivir (Tamiflu) Dosing Strategies for Use During Influenza Prophylaxis (VA01)

US Department of Veterans Affairs·interventional·Posted Mar 17, 2006·Updated Sep 23, 2009

In Brief

A Phase 4 clinical trial evaluating Oseltamivir and Probenecid for Influenza. Completed, enrolled 48 participants across 1 site.

Detailed Summary

Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of Tamiflu and probenecid in healthy adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
CollaboratorsBrooke Army Medical Center, National Institutes of Health (NIH)

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 17, 2006
Enrollment StartFeb 1, 2005
Primary CompletionFeb 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 20.3 years ago

Interventions

Oseltamivirdrug

Probeneciddrug